
Eyereach Meds Llp
Founded in 2020 and headquartered in Tamil Nadu, India.
Founded in 2020 and headquartered in Tamil Nadu, India.
Eyereach Meds Llp (EML) is 4 Year, 8 Months old Limited Liability Partnership 25 September 2020. Its registered office is in Coimbatore, Tamil Nadu, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.50 M as per MCA.
Coimbatore, Tamil Nadu, India
+91-XXXXXXXXXX
AAT-9852
25 Sep 2020
31 Mar 2023
Roc-Coimbatore
Limited Liability Partnership
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dhandapani Ramamurthy ![]() | Designated Partner | 25-Sep-2020 | Current |
Shreyas Ramamurthy ![]() | Designated Partner | 25-Sep-2020 | Current |
Enhance accessibility to Eyereach Meds Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Eyereach Meds Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Dhandapani Ramamurthy and Shreyas Ramamurthy are mutual person
There are no Open Charges registered against the LLP as per our records.
Unlock and access historical data on people associated with Eyereach Meds Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Eyereach Meds Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eyereach Meds Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Eyereach Meds Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with RoC-Coimbatore.
Dhandapani Ramamurthy was appointed as a Designated Partner was appointed as a Designated Partner on 25 Sep 2020 & has been associated with this company since 4 years 8 months .
Shreyas Ramamurthy was appointed as a Designated Partner was appointed as a Designated Partner on 25 Sep 2020 & has been associated with this company since 4 years 8 months .
Eyereach Meds Llp was registered on 25 Sep 2020 with RoC-Coimbatore & aged 4 years 8 months as per MCA records.
Eyereach Meds Llp was incorporated on 25 Sep 2020.
The Obligation of Contribution of Eyereach Meds Llp is ₹ 0.50 M.
Currently 2 partners are associated with Eyereach Meds Llp.
As per Ministry of Corporate Affairs (Mca), the registered address of Eyereach Meds Llp is 583 A The Eye Foundation Next To B V B D Road, R S Puram Na, Coimbatore, Tamil Nadu, India, 641002.
The Limited Liability Partnership Identification Number (LLPIN) of Eyereach Meds Llp is AAT-9852.
The most recent Balance Sheet for Eyereach Meds Llp was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.